Jessica Felton, Kunrong Cheng, Aaron C Shang, Shien Hu, Shannon M Larabee, Cinthia B Drachenberg, Jean-Pierre Raufman
{"title":"Two sides to colon cancer: mice mimic human anatomical region disparity in colon cancer development and progression.","authors":"Jessica Felton, Kunrong Cheng, Aaron C Shang, Shien Hu, Shannon M Larabee, Cinthia B Drachenberg, Jean-Pierre Raufman","doi":"10.20517/2394-4722.2018.39","DOIUrl":"10.20517/2394-4722.2018.39","url":null,"abstract":"<p><strong>Aim: </strong>Strong evidence reveals important differences between cancers in the proximal <i>vs</i>. distal colon. Animal models of metastatic colon cancer are available but with varying degrees of reproducibility and several important limitations. We explored whether there were regional differences in the location of murine colon cancers and assessed the utility of murine models to explore the biological basis for such differences.</p><p><strong>Methods: </strong>We re-analyzed data from our previous studies to assess the regional distribution of murine colon cancer. In survival surgery experiments, we injected HT-29 human colon cancer cells into the wall of the cecum or distal colon of Nu(NCr)-Foxn1<sup>nu</sup> or NOD.Cg-Prkdc<sup>scid</sup>Il2rg<sup>Tim1Wji</sup>/SzJ mice and compared the development of primary tumors and metastases.</p><p><strong>Results: </strong>Within 7-17 weeks after intramural cecal injection of HT-29 cells, eight mice failed to develop solid primary tumors or metastases. In contrast, within four weeks after cell injection into the distal colon, 13 mice developed metastases - 12 mice developed subcutaneous metastases; of these, four developed liver metastases and one developed both liver and lung metastases. One mouse developed liver metastases only. Histological examination confirmed these lesions were adenocarcinomas.</p><p><strong>Conclusion: </strong>Our findings reveal the preferential growth of murine colon neoplasia and invasive human orthotopic xenografts in the distal mouse colon. The new approach of injecting cells into the distal colon wall results in a pattern of colon cancer development that closely mimics the progression of metastatic colon cancer in humans. This novel model of colon neoplasia has great potential for exploring anatomical differences in colon cancer and testing novel therapeutics.</p>","PeriodicalId":15167,"journal":{"name":"Journal of Cancer Metastasis and Treatment","volume":"4 1","pages":""},"PeriodicalIF":1.9,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6860924/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47223058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Giuseppe Galletti, Daniel Worroll, David M Nanus, Paraskevi Giannakakou
{"title":"Using circulating tumor cells to advance precision medicine in prostate cancer.","authors":"Giuseppe Galletti, Daniel Worroll, David M Nanus, Paraskevi Giannakakou","doi":"10.20517/2394-4722.2017.45","DOIUrl":"10.20517/2394-4722.2017.45","url":null,"abstract":"<p><p>The field of CTC enrichment has seen many emerging technologies in recent years, which have resulted in the identification and monitoring of clinically relevant, CTC-based biomarkers that can be analyzed routinely without invasive procedures. Several molecular platforms have been used to investigate the molecular profile of the disease, from high throughput gene expression analyses down to single cell biological dissection. The established presence of CTC heterogeneity nevertheless constitutes a challenge for cell isolation as the several subpopulations can potentially display different molecular characteristics; in this scenario, careful consideration must be given to the isolation approach, whereas methods that discriminate against certain subpopulations may result in the exclusion of CTCs that carry biological relevance. In the context of prostate cancer (PC), CTC molecular interrogation can enable longitudinal monitoring of key biological features during treatment with substantial clinical impact, as several biomarkers could predict tumor response to AR signaling inhibitors (abiraterone, enzalutamide) or standard chemotherapy (taxanes). Thus, CTCs represent a valuable opportunity to personalize medicine in current clinical practice.</p>","PeriodicalId":15167,"journal":{"name":"Journal of Cancer Metastasis and Treatment","volume":"3 ","pages":"190-205"},"PeriodicalIF":1.9,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5913755/pdf/nihms958394.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36054679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Muscarinic receptor signaling and colon cancer progression.","authors":"Guofeng Xie, Jean-Pierre Raufman","doi":"10.20517/2394-4722.2016.05","DOIUrl":"10.20517/2394-4722.2016.05","url":null,"abstract":"<p><p>Due to the lack of effective treatments, advanced colorectal cancer (CRC) remains a leading cause of cancer death in the United States. Emerging evidence supports the observation that muscarinic receptor (MR) signaling plays a critical role in growth and progression of CRC. MR activation by acetylcholine and bile acids results in transactivation of epidermal growth factor receptors (EGFR) and post-EGFR signal transduction that enhances cell proliferation, migration, and invasion. Here, the authors review recent progress in understanding the molecular mechanisms underlying MR-mediated CRC progression and its therapeutic implications.</p>","PeriodicalId":15167,"journal":{"name":"Journal of Cancer Metastasis and Treatment","volume":"2 ","pages":"195-200"},"PeriodicalIF":1.9,"publicationDate":"2016-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/94/da/nihms-1595790.PMC7362988.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38159996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}